SkyLabs Expands Multivital Business With Daewoong Pharmaceutical Supply
AI TIMES ·
✦ AI Summary
According to AI TIMES, SkyLabs signed a supply contract with Daewoong Pharmaceutical on Oct. 1 for ring-type pulse oximeters and will supply…
According to AI TIMES, SkyLabs signed a supply contract with Daewoong Pharmaceutical on Oct. 1 for ring-type pulse oximeters and will supply the initial shipment, worth about KRW 4.9 billion, in the second half of this year in Korea. The product is expected to enter hospital wards and clinics in earnest from the second half of the year, and it is also seen as helping the company reach its sales target of about KRW 10.2 billion for this year. The deal is viewed as a step toward expanding the company’s product lineup, which had centered on blood pressure monitors, to include pulse oximetry. The ring-type device is designed for long-term wear convenience, and the measurement data will be linked with hospital systems to help medical staff check patients’ conditions and respond. Based on this, the company plans to broaden the foundation for collecting various biosignals and strengthen the competitiveness of its platform for analyzing accumulated data. It also plans to accelerate market expansion through overseas distribution networks, using domestic supply as a foothold.
Perspective
The key point in this move is not simply the sale of a new device, but that one company is shifting from a single-measurement focus to a structure that encompasses multiple biosignals. If supply and distribution align, the touchpoints with hospital sites could widen, and that could translate into platform-based competitiveness. In the end, in the industry, not only device performance but also how consistently data is secured and used may become a clearer standard for competition.
This perspective is BizCrush's own commentary and is not part of the reporting by AI TIMES.
This article was produced with the help of an automated content generation algorithm.
Source: AI TIMES
View originalThis article was summarized and organized by BizCrush based on the original article from AI TIMES. For exact quotations and full details, please refer to the original article.